dactinomycin has been researched along with berberine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
| Herdewijn, P; Maiti, M; Nauwelaerts, K | 1 |
| Chao, L | 1 |
| Banerjee, A; Bhadra, K; Islam, MM; Kumar, GS; Maiti, M; Sinha, R | 1 |
| Berge, KE; Cameron, J; Kulseth, MA; Leren, TP; Ranheim, T | 1 |
| Inoue, M; Mizukami, H; Suzuki, H; Tanabe, H | 1 |
6 other study(ies) available for dactinomycin and berberine
| Article | Year |
|---|---|
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Topics: Aminoglycosides; Antineoplastic Agents; Base Sequence; DEAD-box RNA Helicases; Humans; MicroRNAs; Models, Biological; Molecular Sequence Data; Ribonuclease III; RNA Processing, Post-Transcriptional | 2012 |
Regulation of RNA polymerase subunit synthesis in Escherichia coli: utilization of DNA-Intercalating drugs as a probe.
Topics: Acridines; Bacterial Proteins; Berberine; Berberine Alkaloids; Dactinomycin; DNA-Directed RNA Polymerases; Escherichia coli; Ethidium; Peptide Fragments; Proflavine; Rifampin; RNA, Bacterial; RNA, Messenger; Uridine | 1977 |
The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC).poly(rG): spectroscopic and viscometric study.
Topics: Berberine; Binding Sites; Circular Dichroism; Dactinomycin; Distamycins; Ethidium; Fluorescence Polarization; In Vitro Techniques; Intercalating Agents; Methylene Blue; Poly C; Poly G; Protons; Spectrophotometry; Spectrophotometry, Ultraviolet; Viscosity | 2006 |
Berberine decreases PCSK9 expression in HepG2 cells.
Topics: Anticholesteremic Agents; Berberine; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Lovastatin; Plant Extracts; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Endopeptidases; Time Factors; Transcription, Genetic | 2008 |
Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Berberine Alkaloids; Cardiovascular Agents; Cell Line; Cell Line, Tumor; Coptis; Dactinomycin; Drug Resistance, Multiple; Gene Expression Regulation; Genes, MDR; Humans; Membrane Transport Proteins; Mice; Molecular Structure; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rhodamines; RNA, Messenger; Up-Regulation | 2010 |